• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Israel·Industrials·ARAN.TA
Share

Aran Research & Development Stocks

ILA 4489Last Updated 08.10.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

ILA 726964.67288

ILA 4489
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Aran Research & Development (1982) Ltd., an Israeli company founded in Caesarea in 1982, specializes in the design, development, and manufacturing of various products and equipment, with a significant focus on the plastics industry within Israel. The company boasts a broad portfolio, encompassing a wide array of medical devices such as cardiovascular solutions, in-vitro diagnostic tools, surgical instruments, and advanced imaging and monitoring systems. They are also prominent in fluid management, producing water devices like pressure and flow regulators, a variety of valves (electric, hydraulic, air release, check), sprinklers, drippers, taps, water meters, filters, electronic controllers, and specialized testing equipment. Beyond these core areas, Aran provides portable and stationary control systems for unmanned platforms, electro-optical technologies, and robust electronic hardware engineered for demanding ground, marine, and aerial environments. Their offerings extend to ground systems for security and access control, test and measurement equipment, and production line facilities. The company further manufactures specialized printers, automatic beverage dispensers, sophisticated retail technology like computerized shopping carts and self-checkout kiosks, industrial and communication devices, and batteries. Additionally, Aran acts as a supplier for crucial machinery and components, including injection molding machines, robotics and automation systems, injection molds, hot runner systems, drying, dosing, and conveying systems, plasticizing screws and barrels, and ultrasonic welding and cleaning equipment, along with raw materials. The firm also delivers comprehensive support services and makes strategic investments in emerging medical technology startups.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalue

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 19:00

Shares of luxury brands have fallen 25% this year. When can we expect a turnaround, and which ones should we bet on?

09.10.2026 18:49

U.S. stocks rebounded after two days of declines: Is the AI rally continuing?

09.10.2026 17:48

Data center optics are sold out for the next two years — Lumentum. Who else is seeing gains?

09.10.2026 17:26

Deeply Unpopular Stocks: Strategist Recommends Stocks to Ride Out the Sell-Off

09.10.2026 17:15

Shares of biotech company Pacira soared 44%: the maker of "Viagra" is set to acquire it

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026